• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

范可尼贫血症新出现的遗传和分子基础。

The emerging genetic and molecular basis of Fanconi anaemia.

作者信息

Joenje H, Patel K J

机构信息

Department of Clinical Genetics and Human Genetics, and Oncology Research Institute, Free University Medical Centre, Van der Boechorststraat 7, NL-1081 BT, Amsterdam, The Netherlands.

出版信息

Nat Rev Genet. 2001 Jun;2(6):446-57. doi: 10.1038/35076590.

DOI:10.1038/35076590
PMID:11389461
Abstract

The past few years have witnessed a considerable expansion in our understanding of the pathways that maintain chromosome stability in dividing cells through the identification of genes that are mutated in certain human chromosome instability disorders. Cells that are derived from patients with Fanconi anaemia (FA) show spontaneous chromosomal instability and mutagen hypersensitivity, but FA poses a unique challenge as the nature of the DNA-damage-response pathway thought to be affected by the disease has long been a mystery. However, the recent cloning of most of the FA-associated genes, and the characterization of their protein products, has provided tantalizing clues as to the molecular basis of this disease.

摘要

在过去几年中,通过鉴定在某些人类染色体不稳定疾病中发生突变的基因,我们对维持分裂细胞中染色体稳定性的途径的理解有了显著扩展。来自范可尼贫血(FA)患者的细胞表现出自发性染色体不稳定和诱变超敏反应,但FA带来了独特的挑战,因为长期以来被认为受该疾病影响的DNA损伤反应途径的本质一直是个谜。然而,最近大多数与FA相关基因的克隆及其蛋白质产物的表征,为该疾病的分子基础提供了诱人的线索。

相似文献

1
The emerging genetic and molecular basis of Fanconi anaemia.范可尼贫血症新出现的遗传和分子基础。
Nat Rev Genet. 2001 Jun;2(6):446-57. doi: 10.1038/35076590.
2
The Fanconi anaemia/BRCA pathway.范可尼贫血/乳腺癌易感基因通路。
Nat Rev Cancer. 2003 Jan;3(1):23-34. doi: 10.1038/nrc970.
3
Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.范可尼贫血蛋白FANCG与BRCA2/FANCD1的直接相互作用。
Hum Mol Genet. 2003 Oct 1;12(19):2503-10. doi: 10.1093/hmg/ddg266. Epub 2003 Aug 5.
4
Fanconi anaemia and leukaemia - clinical and molecular aspects.范可尼贫血与白血病——临床及分子层面
Br J Haematol. 2004 Jul;126(2):176-91. doi: 10.1111/j.1365-2141.2004.05023.x.
5
The Fanconi Anemia/BRCA pathway: new faces in the crowd.范可尼贫血/乳腺癌易感基因通路:人群中的新面孔。
Genes Dev. 2005 Dec 15;19(24):2925-40. doi: 10.1101/gad.1370505.
6
[From gene to disease: Fanconi anemia].从基因到疾病:范可尼贫血
Ned Tijdschr Geneeskd. 2003 Feb 22;147(8):342-4.
7
The interplay of Fanconi anemia proteins in the DNA damage response.范可尼贫血蛋白在DNA损伤反应中的相互作用。
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1063-9. doi: 10.1016/j.dnarep.2004.04.005.
8
Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.丝裂霉素C和羟基脲处理后范可尼贫血细胞中TP53相关基因的差异表达
Mutat Res. 2008 Oct 30;656(1-2):1-7. doi: 10.1016/j.mrgentox.2008.06.012. Epub 2008 Jul 5.
9
The molecular biology of Fanconi anemia.范可尼贫血的分子生物学
Isr Med Assoc J. 2002 Oct;4(10):819-23.
10
3R coordination by Fanconi anemia proteins.范可尼贫血蛋白的3R协调作用。
Biochimie. 2005 Jul;87(7):647-58. doi: 10.1016/j.biochi.2005.05.003.

引用本文的文献

1
Oncogenic properties of wild-type DNA repair gene FANCA in breast cancer.野生型DNA修复基因FANCA在乳腺癌中的致癌特性。
Cell Rep. 2025 Apr 22;44(4):115480. doi: 10.1016/j.celrep.2025.115480. Epub 2025 Mar 26.
2
Fanconi Anemia: Challenges in Diagnosis and Management-A Case Series Report.范可尼贫血:诊断与管理中的挑战——病例系列报告
Clin Case Rep. 2024 Nov 17;12(11):e9583. doi: 10.1002/ccr3.9583. eCollection 2024 Nov.
3
RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer.
RFWD3调节高级别浆液性卵巢癌对铂类化疗的反应并促进癌症相关表型。
Front Oncol. 2024 Apr 22;14:1389472. doi: 10.3389/fonc.2024.1389472. eCollection 2024.
4
FANCA facilitates G1/S cell cycle advancement, proliferation, migration and invasion in gastric cancer.FANCA 促进胃癌细胞 G1/S 期细胞周期进程、增殖、迁移和侵袭。
Acta Biochim Biophys Sin (Shanghai). 2024 Apr 29;56(7):973-985. doi: 10.3724/abbs.2024045.
5
Fanconi Anemia: A Rare Genetic Disorder.范可尼贫血:一种罕见的遗传性疾病。
Cureus. 2023 May 11;15(5):e38899. doi: 10.7759/cureus.38899. eCollection 2023 May.
6
DNA Damage and Its Role in Cancer Therapeutics.DNA 损伤及其在癌症治疗学中的作用。
Int J Mol Sci. 2023 Mar 1;24(5):4741. doi: 10.3390/ijms24054741.
7
The RPA inhibitor HAMNO sensitizes Fanconi anemia pathway-deficient cells.RPA 抑制剂 HAMNO 增敏范可尼贫血通路缺陷细胞。
Cell Cycle. 2022 Jul;21(14):1468-1478. doi: 10.1080/15384101.2022.2074200. Epub 2022 May 11.
8
Homologous Recombination as a Fundamental Genome Surveillance Mechanism during DNA Replication.同源重组作为 DNA 复制过程中基本的基因组监测机制。
Genes (Basel). 2021 Dec 9;12(12):1960. doi: 10.3390/genes12121960.
9
TGF-β2-induced NEAT1 regulates lens epithelial cell proliferation, migration and EMT by the miR-26a-5p/FANCE axis.转化生长因子-β2诱导的NEAT1通过miR-26a-5p/FANCE轴调节晶状体上皮细胞的增殖、迁移和上皮-间质转化。
Int J Ophthalmol. 2021 Nov 18;14(11):1674-1682. doi: 10.18240/ijo.2021.11.05. eCollection 2021.
10
Disabling the Fanconi Anemia Pathway in Stem Cells Leads to Radioresistance and Genomic Instability.阻断干细胞中的范可尼贫血通路可导致辐射抗性和基因组不稳定性。
Cancer Res. 2021 Jul 1;81(13):3706-3716. doi: 10.1158/0008-5472.CAN-20-3309. Epub 2021 May 3.